Aim & Scope
Drug Design, Development and Therapy is an international, peer-reviewed, open access journal that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines will be a feature of the journal. [1]
2024 - VOLUME 18
P Lei , W Shen , H Tang , ... , W Lu
Drug Design, Development and Therapy , 2024 - VOLUME 18 , pp 1-12.
1
15
J Zhao , C Zhao , T Xun , ... , X Yang
Drug Design, Development and Therapy , 2024 - VOLUME 18 , pp 13-28.
1
35
S Li , Z Lin , H Chen , ... , H Yao
Drug Design, Development and Therapy , 2024 - VOLUME 18 , pp 29-41.
0
39
H Song , B Qiu , X Sun , ... , Z Dong
Drug Design, Development and Therapy , 2024 - VOLUME 18 , pp 43-51.
0
22
Immunosuppression with Generics in Liver and Kidney Transplantation: A Real-World Evidence Study.
M Finocchietti , ML Marino , AC Rosa , ... , CESIT Study Group
Drug Design, Development and Therapy , 2024 - VOLUME 18 , pp 53-69.
0
28
G Del Calvo , CM Pollard , T Baggio Lopez , ... , A Lymperopoulos
Drug Design, Development and Therapy , 2024 - VOLUME 18 , pp 71-80.
3
37
KA Ahmed , A Ibrahim , D Gonzalez , AO Nur
Drug Design, Development and Therapy , 2024 - VOLUME 18 , pp 81-95.
0
30
The Role of Rho Kinase Inhibitors in Corneal Diseases
S Futterknecht , E Chatzimichail , K Gugleta , ... , Z Gatzioufas
Drug Design, Development and Therapy , 2024 - VOLUME 18 , pp 97-108.
Review
1
92
V Tamakauskas , R Žaliūnas , V Lesauskaitė , ... , V Tatarūnas
Drug Design, Development and Therapy , 2024 - VOLUME 18 , pp 109-119.
1
36
J Lee , DW Han , NY Kim , ... , MH Kim
Drug Design, Development and Therapy , 2024 - VOLUME 18 , pp 121-132.
0
33
Editorial Retractions, Expressions of Concern and External Notices
Antitumor Effects of Hydromorphone on Human Gastric Cancer Cells in vitro
B Liang , C Li , Z Zhou , Y Xie
Drug Design, Development and Therapy2023 - VOLUME 17 pp 1037-1045.
1 33
J Ju , N Wang , J Wang , ... , F Chen
Drug Design, Development and Therapy2018 - VOLUME 12 pp 997-1008.
11 25
Z Yu , S Chan , X Wang , ... , W Chen
Drug Design, Development and Therapy2023 - VOLUME 17 pp 993-1006.
3 45
Y Huang , J Chen , S Yang , ... , X Luo
Drug Design, Development and Therapy2020 - VOLUME 14 pp 4625-4637.
15 40
MUK Sahibzada , A Sadiq , HS Faidah , ... , M Kakar
Drug Design, Development and Therapy2018 - VOLUME 12 pp 303-312.
68 42
No authors listed.
Drug Design, Development and Therapy
2024 - VOLUME 18
0 1
PubPeer
2023 - VOLUME 2023, ISSUE 9
0 0
Liposomal flucytosine capped with gold nanoparticle formulations for improved ocular delivery.
Drug Design, Development and Therapy2016 - VOLUME 10 pp 277-295.
19 58
Y Fan , Z Li , L Wu , ... , Y Wang
Drug Design, Development and Therapy2021 - VOLUME 15 pp 1509-1519.
6 47
No authors listed.
Drug Design, Development and Therapy
2023 - VOLUME 17
0 7
PubPeer
2023 - VOLUME 2023, ISSUE 11
0 0
IA Ibrahim , MA Abdulla , M Hajrezaie , ... , M Hasanpourghadi
Drug Design, Development and Therapy2016 - VOLUME 10 pp 93-105.
24 37
No authors listed.
Drug Design, Development and Therapy
2023 - VOLUME 17
0 5
PubPeer
2023 - VOLUME 2023, ISSUE 9
0 0
A Igrunkova , A Fayzullin , S Churbanov , ... , A Shekhter
Drug Design, Development and Therapy2022 - VOLUME 16 pp 349-362.
6 42